Study on Pharmacokinetics of Meperizumab Injection and NUCALA® in Healthy Male Volunteers

NCT05353179 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Granulomatosis With Polyangiitis
Hemophagocytic Syndrome

Interventions

DRUG: Meperizumab injection
DRUG: NUCALA®

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.